BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zeiser R. Immune modulatory effects of statins. Immunology 2018;154:69-75. [PMID: 29392731 DOI: 10.1111/imm.12902] [Cited by in Crossref: 116] [Cited by in F6Publishing: 126] [Article Influence: 29.0] [Reference Citation Analysis]
Number Citing Articles
1 Tajbakhsh A, Gheibihayat SM, Askari H, Savardashtaki A, Pirro M, Johnston TP, Sahebkar A. Statin-regulated phagocytosis and efferocytosis in physiological and pathological conditions. Pharmacology & Therapeutics 2022;238:108282. [DOI: 10.1016/j.pharmthera.2022.108282] [Reference Citation Analysis]
2 Wu B, Chen D, Liao W, Ho W, Yin M, Lin C, Chou C, Peng Y. Statin Therapy and the Risk of Viral Infection: A Retrospective Population-Based Cohort Study. JCM 2022;11:5626. [DOI: 10.3390/jcm11195626] [Reference Citation Analysis]
3 Grievink HW, Smit V, Huisman BW, Gal P, Yavuz Y, Klerks C, Binder CJ, Bot I, Kuiper J, Foks AC, Moerland M. Cardiovascular risk factors: The effects of ageing and smoking on the immune system, an observational clinical study. Front Immunol 2022;13:968815. [DOI: 10.3389/fimmu.2022.968815] [Reference Citation Analysis]
4 De Giorgi R, Cowen PJ, Harmer CJ. Statins in depression: a repurposed medical treatment can provide novel insights in mental health. International Review of Psychiatry. [DOI: 10.1080/09540261.2022.2113369] [Reference Citation Analysis]
5 Vultaggio-poma V, Di Virgilio F. P2 Receptors: Novel Disease Markers and Metabolic Checkpoints in Immune Cells. Biomolecules 2022;12:983. [DOI: 10.3390/biom12070983] [Reference Citation Analysis]
6 Santosa A, Franzén S, Nåtman J, Wettermark B, Parmryd I, Nyberg F. Protective effects of statins on COVID-19 risk, severity and fatal outcome: a nationwide Swedish cohort study. Sci Rep 2022;12:12047. [PMID: 35835835 DOI: 10.1038/s41598-022-16357-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Iannuzzo G, Cuomo G, Di Lorenzo A, Tripaldella M, Mallardo V, Iaccarino Idelson P, Sagnelli C, Sica A, Creta M, Baltar J, Crocetto F, Bresciani A, Gentile M, Calogero A, Giallauria F. Dyslipidemia in Transplant Patients: Which Therapy? JCM 2022;11:4080. [DOI: 10.3390/jcm11144080] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Khalimov YS, Agafonov PV, Kireeva EB. Obesity and COVID-19: insights from two pandemics. jour 2022;14:27-38. [DOI: 10.22625/2072-6732-2022-14-2-27-38] [Reference Citation Analysis]
9 Santoni M, Massari F, Matrana MR, Basso U, De Giorgi U, Aurilio G, Buti S, Incorvaia L, Rizzo M, Martignetti A, Maslov D, Tawagi K, Philon E, Blake Z, Porta C, Battelli N. Statin use improves the efficacy of nivolumab in patients with advanced renal cell carcinoma. Eur J Cancer 2022;172:191-8. [PMID: 35780525 DOI: 10.1016/j.ejca.2022.04.035] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Craig EL, Stopsack KH, Evergren E, Penn LZ, Freedland SJ, Hamilton RJ, Allott EH. Statins and prostate cancer-hype or hope? The epidemiological perspective. Prostate Cancer Prostatic Dis 2022. [PMID: 35732821 DOI: 10.1038/s41391-022-00554-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Pereira PMR, Mandleywala K, Monette S, Lumish M, Tully KM, Panikar SS, Cornejo M, Mauguen A, Ragupathi A, Keltee NC, Mattar M, Janjigian YY, Lewis JS. Caveolin-1 temporal modulation enhances antibody drug efficacy in heterogeneous gastric cancer. Nat Commun 2022;13. [DOI: 10.1038/s41467-022-30142-9] [Reference Citation Analysis]
12 Chen X, Zhang Y, Luo Z, Wu Y, Niu T, Zheng J, Xie Y. Prognostic factors for mortality in bullous pemphigoid: A systematic review and meta-analysis. PLoS One 2022;17:e0264705. [PMID: 35427358 DOI: 10.1371/journal.pone.0264705] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Ghosh D, Ghosh Dastidar D, Roy K, Ghosh A, Mukhopadhyay D, Sikdar N, Biswas NK, Chakrabarti G, Das A. Computational prediction of the molecular mechanism of statin group of drugs against SARS-CoV-2 pathogenesis. Sci Rep 2022;12:6241. [PMID: 35422113 DOI: 10.1038/s41598-022-09845-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 de Medeiros SF, Yamamoto MMW, de Medeiros MAS, Yamamoto AKLW, Barbosa BB. Polycystic ovary syndrome and risks for COVID-19 infection: A comprehensive review : PCOS and COVID-19 relationship. Rev Endocr Metab Disord 2022. [PMID: 35218458 DOI: 10.1007/s11154-022-09715-y] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Teixeira L, Temerozo JR, Pereira-dutra FS, Ferreira AC, Mattos M, Gonçalves BS, Sacramento CQ, Palhinha L, Cunha-fernandes T, Dias SSG, Soares VC, Barreto EA, Cesar-silva D, Fintelman-rodrigues N, Pão CRR, de Freitas CS, Reis PA, Hottz ED, Bozza FA, Bou-habib DC, Saraiva EM, de Almeida CJG, Viola JPB, Souza TML, Bozza PT. Simvastatin Downregulates the SARS-CoV-2-Induced Inflammatory Response and Impairs Viral Infection Through Disruption of Lipid Rafts. Front Immunol 2022;13:820131. [DOI: 10.3389/fimmu.2022.820131] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
16 Rommasi F, Nasiri MJ, Mirsaeidi M. Immunomodulatory agents for COVID-19 treatment: possible mechanism of action and immunopathology features. Mol Cell Biochem 2022. [PMID: 35013850 DOI: 10.1007/s11010-021-04325-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
17 Gogulska Z, Smolenska Z, Turyn J, Mika A, Zdrojewski Z. Lipid Alterations in Systemic Sclerosis. Front Mol Biosci 2021;8:761721. [PMID: 34993231 DOI: 10.3389/fmolb.2021.761721] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Alnasser S, Al-rasheedi M, Alreshidi MA, Alqifari SF, Haider KH. Augmenting Mesenchymal Stem Cell-Based Therapy of the Infarcted Myocardium with Statins. Handbook of Stem Cell Therapy 2022. [DOI: 10.1007/978-981-16-6016-0_20-1] [Reference Citation Analysis]
19 Alnasser S, Al-rasheedi M, Alreshidi MA, Alqifari SF, Haider KH. Augmenting Mesenchymal Stem Cell-Based Therapy of the Infarcted Myocardium with Statins. Handbook of Stem Cell Therapy 2022. [DOI: 10.1007/978-981-19-2655-6_20] [Reference Citation Analysis]
20 Zahedipour F, Guest PC, Majeed M, Al-rasadi K, Jamialahmadi T, Sahebkar A. Multiplex Testing of the Effect of Statins on Disease Severity Risk in COVID-19 Cases. Multiplex Biomarker Techniques 2022. [DOI: 10.1007/978-1-0716-2395-4_20] [Reference Citation Analysis]
21 Alizadeh N, Azimi S, Ramezanzadeh E, Monfared A, Leili E. The impact of underlying diseases-related drugs on the chronic kidney disease-associated pruritus in hemodialysis patients. J Res Med Sci 2022;27:86. [DOI: 10.4103/jrms.jrms_633_21] [Reference Citation Analysis]
22 Jain H, Bhat AR, Dalvi H, Godugu C, Singh SB, Srivastava S. Repurposing approved therapeutics for new indication: Addressing unmet needs in psoriasis treatment. Curr Res Pharmacol Drug Discov 2021;2:100041. [PMID: 34909670 DOI: 10.1016/j.crphar.2021.100041] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
23 Zhang Y, Wang M, Zhang X, Liu T, Libby P, Shi GP. COVID-19, the Pandemic of the Century and Its Impact on Cardiovascular Diseases. Cardiol Discov 2021;1:233-58. [PMID: 34888547 DOI: 10.1097/CD9.0000000000000038] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
24 Kwon M, Nam GH, Jung H, Kim SA, Kim S, Choi Y, Lee YS, Cho HJ, Kim IS. Statin in combination with cisplatin makes favorable tumor-immune microenvironment for immunotherapy of head and neck squamous cell carcinoma. Cancer Lett 2021;522:198-210. [PMID: 34571082 DOI: 10.1016/j.canlet.2021.09.029] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
25 Su S, Liu J, Chen L, Xie E, Geng Q, Zeng H, Yuan Q, Yang F, Luo J. Systemic immune-inflammation index predicted the clinical outcome in patients with type-B aortic dissection undergoing thoracic endovascular repair. Eur J Clin Invest 2021;:e13692. [PMID: 34695253 DOI: 10.1111/eci.13692] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
26 Agur T, Wedel J, Bose S, Sahankumari AGP, Goodman D, Kong SW, Ghosh CC, Briscoe DM. Inhibition of mevalonate metabolism by statins augments the immunoregulatory phenotype of vascular endothelial cells and inhibits the costimulation of CD4+ T cells. Am J Transplant 2021. [PMID: 34687147 DOI: 10.1111/ajt.16872] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
27 Song Y, Liu J, Zhao K, Gao L, Zhao J. Cholesterol-induced toxicity: An integrated view of the role of cholesterol in multiple diseases. Cell Metab 2021;33:1911-25. [PMID: 34562355 DOI: 10.1016/j.cmet.2021.09.001] [Cited by in Crossref: 15] [Cited by in F6Publishing: 23] [Article Influence: 15.0] [Reference Citation Analysis]
28 Leiter A, Carroll E, De Alwis S, Brooks D, Shimol JB, Eisenberg E, Wisnivesky JP, Galsky MD, Gallagher EJ. Metabolic disease and adverse events from immune checkpoint inhibitors. Eur J Endocrinol 2021;184:857-65. [PMID: 34552304 DOI: 10.1530/eje-20-1362] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
29 Tang Y, Hu L, Liu Y, Zhou B, Qin X, Ye J, Shen M, Wu Z, Zhang P. Possible mechanisms of cholesterol elevation aggravating COVID-19. Int J Med Sci 2021;18:3533-43. [PMID: 34522180 DOI: 10.7150/ijms.62021] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
30 Choi D, Chen Q, Goonewardena SN, Pacheco H, Mejia P, Smith RL, Rosenson RS. Efficacy of Statin Therapy in Patients with Hospital Admission for COVID-19. Cardiovasc Drugs Ther 2021. [PMID: 34524566 DOI: 10.1007/s10557-021-07263-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
31 Pourafkari L, Mirza-Aghzadeh-Attari M, Zarrintan A, Mousavi-Aghdas SA. Clinical Experience, Pathophysiology, and Considerations in the Prophylaxis and Treatment of Hypercoagulopathy of COVID-19: A Review Study. Iran J Med Sci 2021;46:1-14. [PMID: 33487787 DOI: 10.30476/ijms.2020.87233.1730] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
32 Esposito L, Cancro FP, Silverio A, Di Maio M, Iannece P, Damato A, Alfano C, De Luca G, Vecchione C, Galasso G. COVID-19 and Acute Coronary Syndromes: From Pathophysiology to Clinical Perspectives. Oxid Med Cell Longev 2021;2021:4936571. [PMID: 34484561 DOI: 10.1155/2021/4936571] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
33 Sumransub N, El Jurdi N, Chiraphapphaiboon W, Maakaron JE. Putting function back in dysfunction: Endothelial diseases and current therapies in hematopoietic stem cell transplantation and cellular therapies. Blood Rev 2021;:100883. [PMID: 34429234 DOI: 10.1016/j.blre.2021.100883] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
34 Balasa R, Barcutean L, Mosora O, Manu D. Reviewing the Significance of Blood-Brain Barrier Disruption in Multiple Sclerosis Pathology and Treatment. Int J Mol Sci 2021;22:8370. [PMID: 34445097 DOI: 10.3390/ijms22168370] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 9.0] [Reference Citation Analysis]
35 Lohia P, Kapur S, Benjaram S, Cantor Z, Mahabadi N, Mir T, Badr MS. Statins and clinical outcomes in hospitalized COVID-19 patients with and without Diabetes Mellitus: a retrospective cohort study with propensity score matching. Cardiovasc Diabetol 2021;20:140. [PMID: 34246277 DOI: 10.1186/s12933-021-01336-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 10.0] [Reference Citation Analysis]
36 Okubo K, Miyai K, Kato K, Asano T, Sato A. Simvastatin-romidepsin combination kills bladder cancer cells synergistically. Transl Oncol 2021;14:101154. [PMID: 34144348 DOI: 10.1016/j.tranon.2021.101154] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Davletshina AY, Lomonosov KM. Pathogenetic justification of the use of simvastatin in the complex therapy of vitiligo. Russian Journal of Skin and Venereal Diseases 2021;24:227-242. [DOI: 10.17816/dv62227] [Reference Citation Analysis]
38 Sell LB, Ramelow CC, Kohl HM, Hoffman K, Bains JK, Doyle WJ, Strawn KD, Hevrin T, Kirby TO, Gibson KM, Roullet JB, Ochoa-Repáraz J. Farnesol induces protection against murine CNS inflammatory demyelination and modifies gut microbiome. Clin Immunol 2021;:108766. [PMID: 34091018 DOI: 10.1016/j.clim.2021.108766] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
39 Cabezón Villalba G, Amat-Santos IJ, Dueñas C, Lopez Otero D, Catala P, Aparisi A, López-Pais J, Cacho Antonio CE, Candela J, Antúnez Muiños P, Gil JF, Gonzalez Ferrero T, Marcos M, Pérez-Poza M, Rojas G, Otero Garcia O, Veras C, Jiménez Ramos V, Uribarri A, Revilla A, Garcia-Granja PE, Gómez I, González-Juanatey JR, San Román JA. Impact of the presence of heart disease, cardiovascular medications and cardiac events on outcome in COVID-19. Cardiol J 2021;28:360-8. [PMID: 33843043 DOI: 10.5603/CJ.a2021.0034] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
40 Diggelmann F, Bengs S, Haider A, Epprecht G, Beeler AL, Etter D, Wijnen WJ, Portmann A, Warnock GI, Treyer V, Grämer M, Todorov A, Mikail N, Rossi A, Fuchs TA, Pazhenkottil AP, Buechel RR, Tanner FC, Kaufmann PA, Gebhard C, Fiechter M. Potential Impact of Statins on Neuronal Stress Responses in Patients at Risk for Cardiovascular Disease. J Pers Med 2021;11:261. [PMID: 33916056 DOI: 10.3390/jpm11040261] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
41 Voth E, Solanky D, Loftus EV Jr, Pardi DS, Khanna S. Novel risk factors and outcomes in inflammatory bowel disease patients with Clostridioides difficile infection. Therap Adv Gastroenterol 2021;14:1756284821997792. [PMID: 33786065 DOI: 10.1177/1756284821997792] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
42 Chamani S, Liberale L, Mobasheri L, Montecucco F, Al-Rasadi K, Jamialahmadi T, Sahebkar A. The role of statins in the differentiation and function of bone cells. Eur J Clin Invest 2021;51:e13534. [PMID: 33656763 DOI: 10.1111/eci.13534] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 11.0] [Reference Citation Analysis]
43 Lohia P, Kapur S, Benjaram S, Mir T. Association between antecedent statin use and severe disease outcomes in COVID-19: A retrospective study with propensity score matching. J Clin Lipidol 2021;15:451-9. [PMID: 33726984 DOI: 10.1016/j.jacl.2021.03.002] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 14.0] [Reference Citation Analysis]
44 Parsamanesh N, Karami-Zarandi M, Banach M, Penson PE, Sahebkar A. Effects of statins on myocarditis: A review of underlying molecular mechanisms. Prog Cardiovasc Dis 2021;67:53-64. [PMID: 33621589 DOI: 10.1016/j.pcad.2021.02.008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 8.0] [Reference Citation Analysis]
45 Kauerova S, Bartuskova H, Muffova B, Janousek L, Fronek J, Petras M, Poledne R, Kralova Lesna I. Statins Directly Influence the Polarization of Adipose Tissue Macrophages: A Role in Chronic Inflammation. Biomedicines 2021;9:211. [PMID: 33669779 DOI: 10.3390/biomedicines9020211] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
46 Oh TK, Song IA, Jeon YT. Statin Therapy and the Risk of COVID-19: A Cohort Study of the National Health Insurance Service in South Korea. J Pers Med 2021;11:116. [PMID: 33578937 DOI: 10.3390/jpm11020116] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 9.0] [Reference Citation Analysis]
47 Lee HY, Ahn J, Park J, Kyung Kang C, Won SH, Wook Kim D, Park JH, Chung KH, Joh JS, Bang JH, Hee Kang C, Bum Pyun W, Oh MD; Korean Society of Hypertension, National Committee for Clinical Management of Emerging Infectious Diseases. Beneficial Effect of Statins in COVID-19-Related Outcomes-Brief Report: A National Population-Based Cohort Study. Arterioscler Thromb Vasc Biol 2021;41:e175-82. [PMID: 33535790 DOI: 10.1161/ATVBAHA.120.315551] [Cited by in Crossref: 24] [Cited by in F6Publishing: 28] [Article Influence: 24.0] [Reference Citation Analysis]
48 Marić I, Oskotsky T, Kosti I, Le B, Wong RJ, Shaw GM, Sirota M, Stevenson DK. Decreased Mortality Rate Among COVID-19 Patients Prescribed Statins: Data From Electronic Health Records in the US. Front Med (Lausanne) 2021;8:639804. [PMID: 33614688 DOI: 10.3389/fmed.2021.639804] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 14.0] [Reference Citation Analysis]
49 Yu D, Liao JK. Emerging views of statin pleiotropy and cholesterol lowering. Cardiovasc Res 2021:cvab032. [PMID: 33533892 DOI: 10.1093/cvr/cvab032] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 21.0] [Reference Citation Analysis]
50 Close RM, Close LM, Galdun P, Gerstberger S, Rydberg M, Christopher-Stine L. Potential implications of six American Indian patients with myopathy, statin exposure and anti-HMGCR antibodies. Rheumatology (Oxford) 2021;60:692-8. [PMID: 32789452 DOI: 10.1093/rheumatology/keaa337] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
51 Zheng DJ, Abou Taka M, Heit B. Role of Apoptotic Cell Clearance in Pneumonia and Inflammatory Lung Disease. Pathogens 2021;10:134. [PMID: 33572846 DOI: 10.3390/pathogens10020134] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
52 Madison JA, Duarte-García A, Zuo Y, Knight JS. Treatment of thrombotic antiphospholipid syndrome in adults and children. Curr Opin Rheumatol 2020;32:215-27. [PMID: 32187042 DOI: 10.1097/BOR.0000000000000702] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
53 Onorato D, Pucci M, Carpene G, Henry BM, Sanchis-Gomar F, Lippi G. Protective Effects of Statins Administration in European and North American Patients Infected with COVID-19: A Meta-Analysis. Semin Thromb Hemost 2021;47:392-9. [PMID: 33482680 DOI: 10.1055/s-0040-1722307] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 20.0] [Reference Citation Analysis]
54 Lohia P, Kapur S, Benjaram S, Pandey A, Mir T, Seyoum B. Metabolic syndrome and clinical outcomes in patients infected with COVID-19: Does age, sex, and race of the patient with metabolic syndrome matter? J Diabetes 2021. [PMID: 33453090 DOI: 10.1111/1753-0407.13157] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 15.0] [Reference Citation Analysis]
55 Zardawi F, Gul S, Abdulkareem A, Sha A, Yates J. Association Between Periodontal Disease and Atherosclerotic Cardiovascular Diseases: Revisited. Front Cardiovasc Med 2020;7:625579. [PMID: 33521070 DOI: 10.3389/fcvm.2020.625579] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 22.0] [Reference Citation Analysis]
56 Esfehani RJ, Vojdanparast M, Soleimanpour S, Ferns GA, Avan A. The Potential Impact of Statins in the Treatment of Patients with COVID-19 Infection. Coronavirus Therapeutics – Volume I 2021. [DOI: 10.1007/978-3-030-85109-5_9] [Reference Citation Analysis]
57 Kim S. Immunomodulatory functions of statins and effects on asthma. Allergy Asthma Respir Dis 2021;9:1. [DOI: 10.4168/aard.2021.9.1.1] [Reference Citation Analysis]
58 Carabott M, Case R, Dhakal S, Macreadie I. Lipids, statins and susceptibility to SARS-CoV-2 and influenza A viruses. Microbiol Aust 2021;42:87. [DOI: 10.1071/ma21021] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
59 Mitacchione G, Schiavone M, Curnis A, Arca M, Antinori S, Gasperetti A, Mascioli G, Severino P, Sabato F, Caracciolo MM, Arabia G, D'Erasmo L, Viecca M, Mancone M, Galli M, Forleo GB. Impact of prior statin use on clinical outcomes in COVID-19 patients: data from tertiary referral hospitals during COVID-19 pandemic in Italy. J Clin Lipidol 2021;15:68-78. [PMID: 33390341 DOI: 10.1016/j.jacl.2020.12.008] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 17.0] [Reference Citation Analysis]
60 Scheen AJ. Statins and clinical outcomes with COVID-19: Meta-analyses of observational studies. Diabetes Metab 2020;47:101220. [PMID: 33359486 DOI: 10.1016/j.diabet.2020.101220] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 10.5] [Reference Citation Analysis]
61 Göbölös L, Rácz I, Hogan M, Remsey-Semmelweis E, Atallah B, AlMahmeed W, AlSindi F, Suri RM, Bhatnagar G, Tuzcu EM. The role of renin-angiotensin system activated phagocytes in the SARS-CoV-2 coronavirus infection. J Vasc Surg 2021;73:1889-97. [PMID: 33348007 DOI: 10.1016/j.jvs.2020.12.056] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
62 Barkas F, Milionis H, Anastasiou G, Liberopoulos E. Statins and PCSK9 inhibitors: What is their role in coronavirus disease 2019? Med Hypotheses 2021;146:110452. [PMID: 33333472 DOI: 10.1016/j.mehy.2020.110452] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 7.5] [Reference Citation Analysis]
63 Li G, Ruan S, Zhao X, Liu Q, Dou Y, Mao F. Transcriptomic signatures and repurposing drugs for COVID-19 patients: findings of bioinformatics analyses. Comput Struct Biotechnol J 2021;19:1-15. [PMID: 33312453 DOI: 10.1016/j.csbj.2020.11.056] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
64 Butt JH, Gerds TA, Schou M, Kragholm K, Phelps M, Havers-Borgersen E, Yafasova A, Gislason GH, Torp-Pedersen C, Køber L, Fosbøl EL. Association between statin use and outcomes in patients with coronavirus disease 2019 (COVID-19): a nationwide cohort study. BMJ Open 2020;10:e044421. [PMID: 33277291 DOI: 10.1136/bmjopen-2020-044421] [Cited by in Crossref: 46] [Cited by in F6Publishing: 46] [Article Influence: 23.0] [Reference Citation Analysis]
65 Ruleva NY, Radyukhina NV, Zubkova ES, Filatova AY, Aref'eva TI. Inhibitors of 3-Hydroxy-3-Methylglutaryl Coenzyme a Reductase (Statins) Suppress Differentiation and Reduce LPS/IFNγ-Induced Cytokine Production in Human Monocyte/Macrophage Culture. Bull Exp Biol Med 2020;170:236-40. [PMID: 33263856 DOI: 10.1007/s10517-020-05042-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
66 Oz M, Lorke DE, Kabbani N. A comprehensive guide to the pharmacologic regulation of angiotensin converting enzyme 2 (ACE2), the SARS-CoV-2 entry receptor. Pharmacol Ther 2021;221:107750. [PMID: 33275999 DOI: 10.1016/j.pharmthera.2020.107750] [Cited by in Crossref: 22] [Cited by in F6Publishing: 27] [Article Influence: 11.0] [Reference Citation Analysis]
67 Bhagavathula AS, Clark C, Rahmani J. Statin use and new-onset of inflammatory bowel disease: A systematic review and meta-analysis of over ten million participants. Eur J Pharmacol 2021;891:173750. [PMID: 33245900 DOI: 10.1016/j.ejphar.2020.173750] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
68 Marazuela M, Giustina A, Puig-Domingo M. Endocrine and metabolic aspects of the COVID-19 pandemic. Rev Endocr Metab Disord. 2020;21:495-507. [PMID: 32643004 DOI: 10.1007/s11154-020-09569-2] [Cited by in Crossref: 83] [Cited by in F6Publishing: 92] [Article Influence: 41.5] [Reference Citation Analysis]
69 Minz MM, Bansal M, Kasliwal RR. Statins and SARS-CoV-2 disease: Current concepts and possible benefits. Diabetes Metab Syndr 2020;14:2063-7. [PMID: 33120281 DOI: 10.1016/j.dsx.2020.10.021] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 10.5] [Reference Citation Analysis]
70 Tan WYT, Young BE, Lye DC, Chew DEK, Dalan R. Statin use is associated with lower disease severity in COVID-19 infection. Sci Rep 2020;10:17458. [PMID: 33060704 DOI: 10.1038/s41598-020-74492-0] [Cited by in Crossref: 68] [Cited by in F6Publishing: 73] [Article Influence: 34.0] [Reference Citation Analysis]
71 Frías Vargas M, Díaz Rodríguez A, Díaz Fernández B. Tratamiento hipolipemiante en la era COVID-19. Medicina de Familia SEMERGEN 2020;46:497-502. [DOI: 10.1016/j.semerg.2020.06.014] [Reference Citation Analysis]
72 Kolan SS, Li G, Wik JA, Malachin G, Guo S, Kolan P, Skålhegg BS. Cellular metabolism dictates T cell effector function in health and disease. Scand J Immunol 2020;92:e12956. [PMID: 32767795 DOI: 10.1111/sji.12956] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
73 Iqbal Z, Ho JH, Adam S, France M, Syed A, Neely D, Rees A, Khatib R, Cegla J, Byrne C, Qureshi N, Capps N, Ferns G, Payne J, Schofield J, Nicholson K, Datta D, Pottle A, Halcox J, Krentz A, Durrington P, Soran H; Heart UK's Medical Scientific and Research Committee. Managing hyperlipidaemia in patients with COVID-19 and during its pandemic: An expert panel position statement from HEART UK. Atherosclerosis 2020;313:126-36. [PMID: 33045618 DOI: 10.1016/j.atherosclerosis.2020.09.008] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 17.5] [Reference Citation Analysis]
74 Tulbah AS. The potential of Atorvastatin for chronic lung diseases therapy. Saudi Pharm J 2020;28:1353-63. [PMID: 33250642 DOI: 10.1016/j.jsps.2020.08.025] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
75 Pang J, Chan DC, Watts GF. The Knowns and Unknowns of Contemporary Statin Therapy for Familial Hypercholesterolemia. Curr Atheroscler Rep 2020;22:64. [PMID: 32870376 DOI: 10.1007/s11883-020-00884-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
76 Bruiners N, Dutta NK, Guerrini V, Salamon H, Yamaguchi KD, Karakousis PC, Gennaro ML. The anti-tubercular activity of simvastatin is mediated by cholesterol-driven autophagy via the AMPK-mTORC1-TFEB axis. J Lipid Res 2020;61:1617-28. [PMID: 32848049 DOI: 10.1194/jlr.RA120000895] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
77 Bleve A, Durante B, Sica A, Consonni FM. Lipid Metabolism and Cancer Immunotherapy: Immunosuppressive Myeloid Cells at the Crossroad. Int J Mol Sci 2020;21:E5845. [PMID: 32823961 DOI: 10.3390/ijms21165845] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 13.0] [Reference Citation Analysis]
78 Gorabi AM, Kiaie N, Bianconi V, Jamialahmadi T, Al-Rasadi K, Johnston TP, Pirro M, Sahebkar A. Antiviral effects of statins. Prog Lipid Res 2020;79:101054. [PMID: 32777243 DOI: 10.1016/j.plipres.2020.101054] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 16.0] [Reference Citation Analysis]
79 Song TJ, Kim J. Effect of Statins on the Risk of Poststroke Pneumonia: National Population-Based Cohort Study. Infect Drug Resist 2020;13:2689-98. [PMID: 32982323 DOI: 10.2147/IDR.S258420] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
80 Minetti G. Mevalonate pathway, selenoproteins, redox balance, immune system, Covid-19: Reasoning about connections. Med Hypotheses 2020;144:110128. [PMID: 32758903 DOI: 10.1016/j.mehy.2020.110128] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
81 Castiglione V, Chiriacò M, Emdin M, Taddei S, Vergaro G. Statin therapy in COVID-19 infection. Eur Heart J Cardiovasc Pharmacother 2020;6:258-9. [PMID: 32347925 DOI: 10.1093/ehjcvp/pvaa042] [Cited by in Crossref: 121] [Cited by in F6Publishing: 126] [Article Influence: 60.5] [Reference Citation Analysis]
82 Kadosh BS, Garshick MS, Gaztanaga J, Moore KJ, Newman JD, Pillinger M, Ramasamy R, Reynolds HR, Shah B, Hochman J, Fishman GI, Katz SD. COVID-19 and the Heart and Vasculature: Novel Approaches to Reduce Virus-Induced Inflammation in Patients With Cardiovascular Disease. Arterioscler Thromb Vasc Biol 2020;40:2045-53. [PMID: 32687400 DOI: 10.1161/ATVBAHA.120.314513] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
83 Mackey RH, Kuller LH, Moreland LW. Inflammatory joint diseases and atherosclerosis: time to look beyond the 'lipid paradox'. Curr Opin Lipidol 2019;30:342-9. [PMID: 31145122 DOI: 10.1097/MOL.0000000000000620] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
84 Lima Martínez MM, Contreras MA, Marín W, D'Marco L. Statins in COVID-19: is there any foundation? Clin Investig Arterioscler 2020;32:278-81. [PMID: 32718669 DOI: 10.1016/j.arteri.2020.06.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
85 Hurwitz LM, Kulac I, Gumuskaya B, Valle JABD, Benedetti I, Pan F, Liu JO, Marrone MT, Arnold KB, Goodman PJ, Tangen CM, Lucia MS, Thompson IM, Drake CG, Isaacs WB, Nelson WG, De Marzo AM, Platz EA. Use of Aspirin and Statins in Relation to Inflammation in Benign Prostate Tissue in the Placebo Arm of the Prostate Cancer Prevention Trial. Cancer Prev Res (Phila) 2020;13:853-62. [PMID: 32581009 DOI: 10.1158/1940-6207.CAPR-19-0450] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
86 Dehnavi S, Sohrabi N, Sadeghi M, Lansberg P, Banach M, Al-Rasadi K, Johnston TP, Sahebkar A. Statins and autoimmunity: State-of-the-art. Pharmacol Ther 2020;214:107614. [PMID: 32592715 DOI: 10.1016/j.pharmthera.2020.107614] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 9.0] [Reference Citation Analysis]
87 Brånvall E, Ekberg S, Eloranta S, Wästerlid T, Birmann BM, Smedby KE. Statin use is associated with improved survival in multiple myeloma: A Swedish population-based study of 4315 patients. Am J Hematol 2020;95:652-61. [PMID: 32141627 DOI: 10.1002/ajh.25778] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
88 Mohammed El Tabaa M, Mohammed El Tabaa M. Targeting Neprilysin (NEP) pathways: A potential new hope to defeat COVID-19 ghost. Biochem Pharmacol 2020;178:114057. [PMID: 32470547 DOI: 10.1016/j.bcp.2020.114057] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 10.0] [Reference Citation Analysis]
89 Abu-Farha M, Thanaraj TA, Qaddoumi MG, Hashem A, Abubaker J, Al-Mulla F. The Role of Lipid Metabolism in COVID-19 Virus Infection and as a Drug Target. Int J Mol Sci 2020;21:E3544. [PMID: 32429572 DOI: 10.3390/ijms21103544] [Cited by in Crossref: 147] [Cited by in F6Publishing: 157] [Article Influence: 73.5] [Reference Citation Analysis]
90 González-Guevara E, Cárdenas G, Pérez-Severiano F, Martínez-Lazcano JC. Dysregulated Brain Cholesterol Metabolism Is Linked to Neuroinflammation in Huntington's Disease. Mov Disord 2020;35:1113-27. [PMID: 32410324 DOI: 10.1002/mds.28089] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
91 Galland S, Martin P, Fregni G, Letovanec I, Stamenkovic I. Attenuation of the pro-inflammatory signature of lung cancer-derived mesenchymal stromal cells by statins. Cancer Lett 2020;484:50-64. [PMID: 32418888 DOI: 10.1016/j.canlet.2020.05.005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
92 Vieira-Silva S, Falony G, Belda E, Nielsen T, Aron-Wisnewsky J, Chakaroun R, Forslund SK, Assmann K, Valles-Colomer M, Nguyen TTD, Proost S, Prifti E, Tremaroli V, Pons N, Le Chatelier E, Andreelli F, Bastard JP, Coelho LP, Galleron N, Hansen TH, Hulot JS, Lewinter C, Pedersen HK, Quinquis B, Rouault C, Roume H, Salem JE, Søndertoft NB, Touch S, Dumas ME, Ehrlich SD, Galan P, Gøtze JP, Hansen T, Holst JJ, Køber L, Letunic I, Nielsen J, Oppert JM, Stumvoll M, Vestergaard H, Zucker JD, Bork P, Pedersen O, Bäckhed F, Clément K, Raes J; MetaCardis Consortium. Statin therapy is associated with lower prevalence of gut microbiota dysbiosis. Nature 2020;581:310-5. [PMID: 32433607 DOI: 10.1038/s41586-020-2269-x] [Cited by in Crossref: 147] [Cited by in F6Publishing: 156] [Article Influence: 73.5] [Reference Citation Analysis]
93 Katsiki N, Banach M, Mikhailidis DP. Lipid-lowering therapy and renin-angiotensin-aldosterone system inhibitors in the era of the COVID-19 pandemic. Arch Med Sci 2020;16:485-9. [PMID: 32399093 DOI: 10.5114/aoms.2020.94503] [Cited by in Crossref: 50] [Cited by in F6Publishing: 56] [Article Influence: 25.0] [Reference Citation Analysis]
94 Genkel VV, Shaposhnik II. Inflammatory Bowel Disease and Statins. Rossijskij žurnal gastroènterologii, gepatologii, koloproktologii 2020;30:7-13. [DOI: 10.22416/1382-4376-2020-30-1-7-13] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
95 Ajdidi A, Sheehan G, Kavanagh K. Exposure of Aspergillus fumigatus to Atorvastatin Leads to Altered Membrane Permeability and Induction of an Oxidative Stress Response. J Fungi (Basel) 2020;6:E42. [PMID: 32225059 DOI: 10.3390/jof6020042] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
96 Sapey E, Patel JM, Greenwood H, Walton GM, Grudzinska F, Parekh D, Mahida RY, Dancer RCA, Lugg ST, Howells PA, Hazeldine J, Newby P, Scott A, Nightingale P, Hill AT, Thickett DR. Simvastatin Improves Neutrophil Function and Clinical Outcomes in Pneumonia. A Pilot Randomized Controlled Clinical Trial. Am J Respir Crit Care Med 2019;200:1282-93. [PMID: 31206313 DOI: 10.1164/rccm.201812-2328OC] [Cited by in Crossref: 59] [Cited by in F6Publishing: 62] [Article Influence: 29.5] [Reference Citation Analysis]
97 Peppas S, Piovani D, Peyrin-Biroulet L, Danese S, Bonovas S. Statins and inflammatory bowel disease: Where do we stand? Eur J Intern Med 2020;75:10-4. [PMID: 32151491 DOI: 10.1016/j.ejim.2020.02.017] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
98 Bruiners N, Dutta NK, Guerrini V, Salamon H, Yamaguchi KD, Karakousis PC, Gennaro ML. The anti-tubercular activity of simvastatin is mediated by cholesterol-dependent regulation of autophagy via the AMPK-mTORC1-TFEB axis.. [DOI: 10.1101/2020.03.04.977579] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
99 Chait A, den Hartigh LJ. Adipose tissue distribution, inflammation and its metabolic consequences, including diabetes and cardiovascular disease. Front Cardiovasc Med. 2020;7:22. [PMID: 32158768 DOI: 10.3389/fcvm.2020.00022] [Cited by in Crossref: 293] [Cited by in F6Publishing: 314] [Article Influence: 146.5] [Reference Citation Analysis]
100 Lin CC, Lin WN, Cho RL, Yang CC, Yeh YC, Hsiao LD, Tseng HC, Yang CM. Induction of HO-1 by Mevastatin Mediated via a Nox/ROS-Dependent c-Src/PDGFRα/PI3K/Akt/Nrf2/ARE Cascade Suppresses TNF-α-Induced Lung Inflammation. J Clin Med 2020;9:E226. [PMID: 31952230 DOI: 10.3390/jcm9010226] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 9.5] [Reference Citation Analysis]
101 De Sanctis JB. Pharmacologic Modulation of the Immune Response Against Tumours in the Elderly. Drug Targets in Cellular Processes of Cancer: From Nonclinical to Preclinical Models 2020. [DOI: 10.1007/978-981-15-7586-0_8] [Reference Citation Analysis]
102 Li G, Zhao X, Liu Q, Ruan S, Dou Y, Mao F. Transcriptomic Signatures and Immunomodulatory Treatments for COVID-19 Patients. SSRN Journal. [DOI: 10.2139/ssrn.3620818] [Reference Citation Analysis]
103 Koch CA, Krabbe S, Hehmke B. Effect of atorvastatin on rheumatoid arthritis-associated autoreactive T cells. Immunol Res 2019;67:297-300. [PMID: 31760564 DOI: 10.1007/s12026-019-09105-8] [Reference Citation Analysis]
104 Karmaus PW, Shi M, Perl S, Biancotto A, Candia J, Cheung F, Kotliarov Y, Young N, Fessler MB; CHI Consortium. Effects of rosuvastatin on the immune system in healthy volunteers with normal serum cholesterol. JCI Insight 2019;4:131530. [PMID: 31573980 DOI: 10.1172/jci.insight.131530] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
105 Jukema RA, Ahmed TAN, Tardif JC. Does low-density lipoprotein cholesterol induce inflammation? If so, does it matter? Current insights and future perspectives for novel therapies. BMC Med 2019;17:197. [PMID: 31672136 DOI: 10.1186/s12916-019-1433-3] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 6.0] [Reference Citation Analysis]
106 Alkuraishy HM, Al-Gareeb AI, Waheed HJ. Lipoprotein-Associated Phospholipase A2 is Linked with Poor Cardio-Metabolic Profile in Patients with Ischemic Stroke: A Study of Effects of Statins. J Neurosci Rural Pract 2018;9:496-503. [PMID: 30271040 DOI: 10.4103/jnrp.jnrp_97_18] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
107 Ajdidi A, Sheehan G, Abu Elteen K, Kavanagh K. Assessment of the in vitro and in vivo activity of atorvastatin against Candida albicans. J Med Microbiol 2019;68:1497-506. [PMID: 31460860 DOI: 10.1099/jmm.0.001065] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
108 Ntolkeras G, Barba C, Mavropoulos A, Vasileiadis GK, Dardiotis E, Sakkas LI, Hadjigeorgiou G, Bogdanos DP. On the immunoregulatory role of statins in multiple sclerosis: the effects on Th17 cells. Immunol Res 2019;67:310-24. [DOI: 10.1007/s12026-019-09089-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
109 Shahoei SH, Nelson ER. Nuclear receptors, cholesterol homeostasis and the immune system. J Steroid Biochem Mol Biol 2019;191:105364. [PMID: 31002862 DOI: 10.1016/j.jsbmb.2019.04.013] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
110 Christie CF, Fang D, Hunt EG, Morris ME, Rovini A, Heslop KA, Beeson GC, Beeson CC, Maldonado EN. Statin-dependent modulation of mitochondrial metabolism in cancer cells is independent of cholesterol content. FASEB J 2019;33:8186-201. [PMID: 30951369 DOI: 10.1096/fj.201802723R] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 6.7] [Reference Citation Analysis]
111 Andersen CJ, Vance TM. Gender Dictates the Relationship between Serum Lipids and Leukocyte Counts in the National Health and Nutrition Examination Survey 1999⁻2004. J Clin Med 2019;8:E365. [PMID: 30875952 DOI: 10.3390/jcm8030365] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
112 Tradtrantip L, Duan T, Yeaman MR, Verkman AS. CD55 upregulation in astrocytes by statins as potential therapy for AQP4-IgG seropositive neuromyelitis optica. J Neuroinflammation 2019;16:57. [PMID: 30851734 DOI: 10.1186/s12974-019-1448-x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
113 Petit C, Batool F, Bugueno IM, Schwinté P, Benkirane-Jessel N, Huck O. Contribution of Statins towards Periodontal Treatment: A Review. Mediators Inflamm 2019;2019:6367402. [PMID: 30936777 DOI: 10.1155/2019/6367402] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 11.7] [Reference Citation Analysis]
114 Chen Y, Li X, Zhang R, Xia Y, Shao Z, Mei Z. Effects of statin exposure and lung cancer survival: A meta-analysis of observational studies. Pharmacol Res 2019;141:357-65. [PMID: 30641276 DOI: 10.1016/j.phrs.2019.01.016] [Cited by in Crossref: 10] [Cited by in F6Publishing: 16] [Article Influence: 3.3] [Reference Citation Analysis]
115 Hedin U, Matic LP. Recent advances in therapeutic targeting of inflammation in atherosclerosis. J Vasc Surg 2019;69:944-51. [PMID: 30591299 DOI: 10.1016/j.jvs.2018.10.051] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
116 Burhans MS, Hagman DK, Kuzma JN, Schmidt KA, Kratz M. Contribution of Adipose Tissue Inflammation to the Development of Type 2 Diabetes Mellitus. Compr Physiol 2018;9:1-58. [PMID: 30549014 DOI: 10.1002/cphy.c170040] [Cited by in Crossref: 83] [Cited by in F6Publishing: 133] [Article Influence: 20.8] [Reference Citation Analysis]
117 Gremese E, DE Lorenzis E, Ferraccioli GF. Statins and Mortality in Connective Tissue Diseases: Should We Resume the Cardio-rheumatology Spirit in Our Clinics? J Rheumatol 2018;45:1617-9. [PMID: 30504479 DOI: 10.3899/jrheum.180732] [Reference Citation Analysis]
118 Rozenblat M, Halaj A, Rozenblat T, Fisher S, Sah M, Dodiuk-Gad RP, Ziv M. Mortality and risk factors among Israeli bullous pemphigoid patients. Arch Dermatol Res 2019;311:19-27. [PMID: 30382340 DOI: 10.1007/s00403-018-1875-z] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
119 Lin YH, Chen YH, Chang HY, Au HK, Tzeng CR, Huang YH. Chronic Niche Inflammation in Endometriosis-Associated Infertility: Current Understanding and Future Therapeutic Strategies. Int J Mol Sci 2018;19:E2385. [PMID: 30104541 DOI: 10.3390/ijms19082385] [Cited by in Crossref: 56] [Cited by in F6Publishing: 60] [Article Influence: 14.0] [Reference Citation Analysis]
120 Dantzer R, Cohen S, Russo SJ, Dinan TG. Resilience and immunity. Brain Behav Immun 2018;74:28-42. [PMID: 30102966 DOI: 10.1016/j.bbi.2018.08.010] [Cited by in Crossref: 94] [Cited by in F6Publishing: 98] [Article Influence: 23.5] [Reference Citation Analysis]
121 Rees S. A practical guide to prescribing statins in primary care. Practice Nursing 2018;29:377-382. [DOI: 10.12968/pnur.2018.29.8.377] [Reference Citation Analysis]